Media Summary: In the last few years, the pharmaceutical industry has invested in developing Complex Biologics including proteins, ... Frank Rigo, PhD, Isis Pharmaceuticals, discusses Exon Skipping. PUBLISHED 05/01/2019 In this episode Dr. Steve Perrin, CEO at the ALS
How Does It Work Antisense Oligonucleotide Therapy - Detailed Analysis & Overview
In the last few years, the pharmaceutical industry has invested in developing Complex Biologics including proteins, ... Frank Rigo, PhD, Isis Pharmaceuticals, discusses Exon Skipping. PUBLISHED 05/01/2019 In this episode Dr. Steve Perrin, CEO at the ALS Chair, Jinsy A. Andrews, MD, MSc, FAAN, discusses amyotrophic lateral sclerosis in this CME activity titled “A Visual Exploration ... Anne Smith, Executive Director, Clinical Development at Ionis Pharmaceuticals Anne Smith, PhD, Presenter Biography …………… Robert MacLeod Dr. MacLeod
Dr. Huda Zoghbi has made critical contributions to the MECP2 Duplication Syndrome (MDS) field. Among the most important has ... Speaker: Leigh Felton, GlaxoSmithKline, United Kingdom Presented at Session 4: Update on Viral Targets for HBV/HDV After decades of research and development, synthetic nucleic acids are beginning to enjoy significant success in the clinic.
